[ad_1]
Dallas, Texas, August 24, 2019 (GLOBE NEWSWIRE) – Regarding this report, NGS is a technology for sequencing millions of strands of DNA through mbadive parallelization. this technique is also called high throughput sequencing. The low cost, high accuracy and speed, as well as precise results, even with a small number of samples, are the main advantages offered by NGS compared to the Sanger sequencing method. NGS is therefore used to perform various applications, such as biomarker discovery, oncology studies, personalized medicine and agricultural and animal research, among others. Thus, the NGS market has transformed the landscape of genomics and molecular diagnostics.
Key factors, such as increasing the number of NGS applications, speed, cost and accuracy, effective replacement of traditional technologies and drug discovery applications requiring NGS technology should drive market growth global.
Request a sample @ https: //www.orbisresearch.com/contacts/request-sample/3585369
The speed, cost and accuracy of NGS technology contribute to the growth of the market. This goal is achieved with the help of modern DNA sequencing technology, which has helped in the sequencing of complete DNA sequences of many types and species of life. It has also been found that NGS is significantly cheaper, faster and requires much less DNA, which contributes to the overall growth of the market.
The NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetic markers to personalize its treatments.
Various technological advances in the field of medicine are developing rapidly and have led to the development of personalized medicine. There are a large number of new generation sequencing applications in personalized medicine. Thus, the development of personalized medicine has opened many avenues for the application of the NGS, which could accelerate market growth.
The current market also faces challenges because of the complexity of managing large data and the complications badociated with managing large data. In addition, some ethical issues badociated with whole-genome sequencing, coupled with lack of public awareness, are holding back market growth.
Key Market Trends
Genetic testing is the fastest-growing segment under application expected during the forecast period
In genetic testing, the NGS is very useful for identifying monogenic heterogeneity of locus diseases, such as blindness, deafness, movement disorders, mitochondrial diseases, hereditary cancers, etc. Therefore, NGS has a large number of diverse applications via genetic screening in multiple disorders, but their price and availability in high and low income countries can vary widely. All genomes are mapped at affordable costs. Thus, sustained growth is expected over the forecast period.
NGS is also becoming a promising method of detecting pathogens for the diagnosis of infectious diseases. It badists in the identification and genomic characterization of bacteria, fungi, parasites and viruses, without it being necessary to previously know a specific pathogen, directly from clinical specimens . As diseases caused by infections increase in less developed countries, diagnosis of these infections based on NGS has become the most promising method for detecting these infectious diseases. The NGS also has applications in personalized medicine that are becoming a reality and have been applied by various biotech companies.
Browse the full report @ https: //www.orbisresearch.com/reports/index/next-generation-sequencing-ngs-growth-trends-and-forecast-2019-2024
The Asia-Pacific region is the fastest growing market and is expected to follow the same trend over the forecast period
The studied market is expected to grow fastest in Asia Pacific. Key market players are increasingly focusing on providing advanced and efficient NGS technologies to developing countries to meet genomic drug and whole genome sequencing needs for personalized medicine. In addition, the growing adoption of NGS technology by non-governmental and governmental organizations, as well as the increased investment of private players, should stimulate the Asian market.
Competitive landscape
Large biotech industries are investing heavily in evolving preventative vaccines and therapeutic vaccines that can stop or cure diseases ranging from viruses to cancers. The biotechnology sector is therefore using the NGS to develop advanced diagnostic kits to detect pathologies and infectious diseases.
Direct purchase of a single-user copy @ https://www.orbisresearch.com/contact/purchase-single-user/3585369
Main points of the table of contents:
1. INTRODUCTION
2 SEARCH METHODOLOGY
3 SUMMARY
4 MARKET DYNAMICS
5 SEGMENTATION OF THE MARKET
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Continued…
About us:
Orbis Research (orbisresearch.com) is a one-time help for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in providing customized reports according to the requirements of our clients. We have complete information about our publishers and are therefore certain of the accuracy of industries and vertical branches of their specialization. It helps our customers identify their needs and we produce the perfect market research required by our customers.
Contact us:
Hector Costello
Senior Manager – Customer Engagement
Highway 4144N,
Suite 600, Dallas,
Texas – 75204, United States
Phone: +1 (214) 884-6817; +91 895 659 5155
Email ID: [email protected]
Follow us on Linkedin: https://www.linkedin.com/company/orbisresearch
Source link
